Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ofid/ofx009 http://scihub22266oqcxt.onion/10.1093/ofid/ofx009 C5414027!5414027!28480282     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28480282&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Open+Forum+Infect+Dis 2017 ; 4 (1): ä Nephropedia Template TP {{tp|p=28480282|t=2017. Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika |pdf=|usr=}}{{28480282}} gab.com Text Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika JO: Open Forum Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=28480282 #FOAvip Zika virus (ZIKV) infection can be the cause of congenital malformations, including microcephaly in infants and can cause other disorders such as Guillain-Barré syndrome, meningoencephalitis, and myelitis, which can also occur in some infected adults. However, at this time, there is no drug approved to treat ZIKV infection. Drug repurposing is the promptest way to obtain an effective drug during a global public health emergency such as the spread of Zika virus. In this study, we report a US Food and Drug Admistration-approved drug that is safe for pediatric use. Nitazoxanide and its bioactive metabolite, tizoxanide, have anti-ZIKV potential in vitro, and we identified that they exerts antiviral effect possibly by targeting the viral postattachment step. Twit Text FOAVip Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika ????Open Forum Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=28480282 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28480282 #FOAvip English Wikipedia <ref>{{Cite pmid|28480282}}</ref> Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika #MMPMID28480282 Cao RY; Xu Yf; Zhang TH; Yang JJ; Yuan Y; Hao P; Shi Y; Zhong J; Zhong W Open Forum Infect Dis 2017[Win]; 4 (1): ä PMID28480282show ga Zika virus (ZIKV) infection can be the cause of congenital malformations, including microcephaly in infants and can cause other disorders such as Guillain-Barré syndrome, meningoencephalitis, and myelitis, which can also occur in some infected adults. However, at this time, there is no drug approved to treat ZIKV infection. Drug repurposing is the promptest way to obtain an effective drug during a global public health emergency such as the spread of Zika virus. In this study, we report a US Food and Drug Admistration-approved drug that is safe for pediatric use. Nitazoxanide and its bioactive metabolite, tizoxanide, have anti-ZIKV potential in vitro, and we identified that they exerts antiviral effect possibly by targeting the viral postattachment step. äPediatric Drug Nitazoxanide: A Potential Choice for Control of Zika (epmc).pdf DeepDyve Pubget Overpricing